Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...

GRAMMY-winning trumpeter Chris Botti has been one of the most popular instrumentalists in the world for nearly three decades; he’s collaborated with some of the biggest superstars on the planet, ...